Artivion, Inc. (AORT)

NYSE: AORT · USD

$22.8

-0.11 (-0.5%)· Recorded snapshot

Market cap	1.1B
Revenue (ttm)	471.5M
Net income (ttm)	-3.2M
EPS (ttm)	-$0.07
Shares out	48.8M
P/E (forward)	223.8x
Volume	313,675
Beta	1.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 471.5M
Net income (ttm): -3.2M
EPS (ttm): -$0.07
P/E (forward): 223.8x
Market cap: 1.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E223.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-0.7

P25 n/aP50 n/aP75 n/a

ROIC-7.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AORT indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000784199
Company name	Artivion, Inc.
Country	United States
Country code	US
CUSIP number	228903100
Earnings date	2026-11-05
Earnings time	amc
Employees	1,800
Employees change	200
Employees growth	12.5%
Enterprise value	$1.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1984
In index	RUSSELL2000
Industry	Medical Devices
IPO date	1993-02-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US2289031005
Last 10-K release date	2026-02-18
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2000-12-28
Last stock split type	Forward
Market cap	$1.1B
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$22.83
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	AORT
U.S. state	Georgia
Website	https://artivion.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	42.28x
Earnings yield	-0.29%
EV/EBIT	36.75x
EV/EBITDA	22.58x
EV/Sales	3.05x
FCF / EV yield	-0.64%
FCF yield	-0.83%
Forward EV/Sales	2.78x
Forward P/E	223.78x
Forward P/S	2.14x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/(OCF - SBC) ratio	74.31x
P/B ratio	2.51x
P/OCF ratio	26.57x
P/S ratio	2.35x
Price/EBITDA ratio	17.39x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	8.3%
EBITDA margin	13.51%
Effective tax rate	241.74%
Gross margin	64.37%
Operating margin	8.3%
Pretax margin	0.47%
Profit margin	-0.67%
Profit per employee	$-1,773
Profitable years	1
Revenue per employee	$261,930
ROA	2.56%
ROA (5Y)	0.75%
ROCE	4.06%
ROE	-0.73%
ROE (5Y)	-4.84%
ROIC	-7.77%
ROIC (5Y)	1.3%
SBC / revenue	5.68%
Tax / revenue	1.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Gross profit growth	17.09%
Gross profit growth (Q)	10.13%
Gross profit growth 3Y	12.8%
Gross profit growth 5Y	10.28%
Net income growth years	2
OCF growth	112.24%
OCF growth 10Y	13.19%
OCF growth 3Y	109.84%
OCF growth 5Y	26.78%
Operating income growth	76.81%
Operating income growth (Q)	3.2%
Operating income growth 3Y	205.22%
Operating income growth 5Y	18.01%
Revenue growth	16.4%
Revenue growth (Q)	11.32%
Revenue growth (QoQ)	8.1%
Revenue growth 10Y	10.96%
Revenue growth 3Y	12.77%
Revenue growth 5Y	10.96%
Revenue growth quarters	22
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-50.9M
Depreciation and amortization	$24.6M
EBIT	$39.2M
EBITDA	$63.7M
EPS	$-0.07
FCF per share	$-0.19
Financing cash flow	$157.6M
Free cash flow	$-9.2M
Free cash flow minus SBC	$-36M
Gross profit	$303.5M
Income taxes	$5.4M
Investing cash flow	$-175M
Net borrowing	$145.7M
Net cash flow	$23.8M
Net income	$-3.2M
Operating cash flow minus SBC	$14.9M
Operating income	$39.2M
Revenue	$471.5M
Stock-based compensation	$26.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.48
Book value per share	$9.15
Debt / EBITDA	5.72
Debt / equity	0.92
Goodwill	$349.9M
Interest coverage	1.61
Long-term assets	$700.6M
Long-term liabilities	$519.4M
Net cash (debt)	$-330.7M
Net cash / market cap	-29.84%
Net debt / EBITDA	5.19
Net debt / equity	0.74
Piotroski F-Score	4
Property, plant and equipment	$110.3M
Shareholders' equity	$445.6M
Tangible book value	$-128.2M
Tangible book value per share	$-2.63
Total assets	$1.1B
Total cash	$77.3M
Total debt	$408M
Total liabilities	$626.3M
WACC	5.74%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.49
Current assets	$371.4M
Current liabilities	$106.9M
Current ratio	3.47
Inventory turnover	1.77
Net working capital	$193.1M
Quick ratio	1.76
Working capital	$264.4M
Working capital turnover	1.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-12.42%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.03
Shareholder yield	-12.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	36.24%
10Y return CAGR	3.14%
10Y total return	36.24%
150-day SMA	$26.44
15Y price change	367.62%
15Y return CAGR	11.18%
15Y total return	390.29%
1D price change	-0.48%
1M price change	0.84%
1M total return	0.84%
1W price change	-1.17%
1W total return	-1.17%
1Y price change	-48.99%
1Y return CAGR	-49.02%
1Y total return	-48.99%
20-day SMA	$22.27
200-day SMA	$29.59
20Y price change	290.09%
20Y return CAGR	7.3%
20Y total return	308.99%
3M price change	-12.57%
3M total return	-12.57%
3Y price change	85.08%
3Y return CAGR	22.77%
3Y total return	85.08%
50-day SMA	$24.08
50-day SMA vs 200-day SMA	50under200
52-week high	$48.25
52-week high date	2025-12-17
52-week low	$19.16
52-week low date	2026-05-08
5Y price change	10.4%
5Y return CAGR	2%
5Y total return	10.4%
6M price change	-38.37%
6M total return	-38.37%
All-time high	$48.25
All-time high date	2025-12-17
All-time low	$1.40
All-time low date	2002-08-15
Average true range (ATR)	$0.95
Average volume	484.4K
Beta (1Y)	0.13
Beta (2Y)	0.62
Beta (5Y)	1.22
Change from 52-week high	-52.68%
Change from 52-week low	19.15%
Change from all-time high	-52.7%
Change from all-time low	1,530%
Change from open	-0.74%
Day's gap	0.26%
Dollar volume	$7.2M
High price	$23.32
Low price	$22.83
Monthly RSI	40.74
Open price	$23.00
Position in 52-week range	0%
Previous close	$22.94
Price vs 150-day SMA	-13.69%
Price vs 20-day SMA	2.47%
Price vs 200-day SMA	-22.87%
Price vs 50-day SMA	-5.24%
Relative volume	0.65
RSI	48.69
Sharpe ratio	-1.21
Sharpe ratio (3Y)	0.54
Sharpe ratio (5Y)	0.18
Sortino ratio	-1.34
Sortino ratio (3Y)	0.95
Sortino ratio (5Y)	0.38
Volume	313.7K
Weekly RSI	37.79
YTD price change	-49.97%
YTD total return	-49.97%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46.3M
Float percentage	94.91%
Shares change (QoQ)	-2.39%
Shares change (YoY)	12.42%
Shares held by insiders	5.07%
Shares held by institutions	96.5%
Shares outstanding	48.8M
Short % of float	7.83%
Short % of shares	7.43%
Short ratio	5.7 days

Deeper analysis on AORT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AORT report

Is a complete AORT research report available?

No complete published report is available for Artivion, Inc. (AORT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Artivion, Inc. (AORT)

Price

Financial snapshot

Fair-value bridge

Latest news · AORT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AORT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AORT

Frequently asked questions